These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1089 related articles for article (PubMed ID: 29869799)

  • 1. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
    Candy B; Jones L; Vickerstaff V; Larkin PJ; Stone P
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006332. PubMed ID: 29869799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
    Candy B; Jones L; Vickerstaff V; Larkin PJ; Stone P
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD006332. PubMed ID: 36106667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu-opioid antagonists for opioid-induced bowel dysfunction.
    McNicol ED; Boyce D; Schumann R; Carr DB
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006332. PubMed ID: 18425947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laxatives or methylnaltrexone for the management of constipation in palliative care patients.
    Candy B; Jones L; Goodman ML; Drake R; Tookman A
    Cochrane Database Syst Rev; 2011 Jan; (1):CD003448. PubMed ID: 21249653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis.
    Kistemaker KRJ; Sijani F; Brinkman DJ; de Graeff A; Burchell GL; Steegers MAH; van Zuylen L
    Cancer Treat Rev; 2024 Apr; 125():102704. PubMed ID: 38452708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Thomas J; Karver S; Cooney GA; Chamberlain BH; Watt CK; Slatkin NE; Stambler N; Kremer AB; Israel RJ
    N Engl J Med; 2008 May; 358(22):2332-43. PubMed ID: 18509120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxycodone for cancer-related pain.
    Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD003870. PubMed ID: 28829910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxycodone for cancer-related pain.
    Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS; Page AJ; Chi Y
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD003870. PubMed ID: 35679121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials.
    Hale M; Wild J; Reddy J; Yamada T; Arjona Ferreira JC
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):555-564. PubMed ID: 28576452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.
    Mori M; Ji Y; Kumar S; Ashikaga T; Ades S
    Int J Clin Oncol; 2017 Apr; 22(2):397-404. PubMed ID: 27628064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
    Nee J; Zakari M; Sugarman MA; Whelan J; Hirsch W; Sultan S; Ballou S; Iturrino J; Lembo A
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxycodone for neuropathic pain in adults.
    Gaskell H; Derry S; Stannard C; Moore RA
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010692. PubMed ID: 27465317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydromorphone for cancer pain.
    Li Y; Ma J; Lu G; Dou Z; Knaggs R; Xia J; Zhao S; Dong S; Yang L
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD011108. PubMed ID: 34350974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
    Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
    J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laxatives for the management of constipation in people receiving palliative care.
    Candy B; Jones L; Larkin PJ; Vickerstaff V; Tookman A; Stone P
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD003448. PubMed ID: 25967924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
    Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
    Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis.
    Ford AC; Brenner DM; Schoenfeld PS
    Am J Gastroenterol; 2013 Oct; 108(10):1566-74; quiz 1575. PubMed ID: 23752879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.
    Slatkin N; Thomas J; Lipman AG; Wilson G; Boatwright ML; Wellman C; Zhukovsky DS; Stephenson R; Portenoy R; Stambler N; Israel R
    J Support Oncol; 2009; 7(1):39-46. PubMed ID: 19278178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
    Leppert W
    Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral tapentadol for cancer pain.
    Wiffen PJ; Derry S; Naessens K; Bell RF
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011460. PubMed ID: 26403220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.